# Natural Capsules (NSE: NATCAPSUQ) share price, financials and shareholding

Source: https://app.pivotnow.in/stock/NATCAPSUQ · Pivot · prices to 22 Oct 2026

Natural Capsules (NSE: NATCAPSUQ) closed at ₹150.40 on 22 Oct 2026, down 2.21% on the day. With a market capitalisation of ₹157 Cr, it ranks 2408th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Drug Manufacturers - Specialty & Generic.

Its return on equity was −7.7% in FY26. Over the past year the share price has fallen 34.6%. Its 52-week range is ₹136.36 (27 Mar 2026) to ₹234.00 (4 Sep 2026); the last close is 35.7% below the high. In Q4 FY26, the quarter ended 31 Mar 2026, revenue was ₹58 Cr (+30.0% year on year) and net profit −₹5 Cr (−1,057.7%), on a consolidated basis. Promoters held 50.92% of the company as of 30 Jun 2026.

## Key numbers

| Metric | Value |
| --- | --- |
| Last close | ₹150.40 |
| Market cap | ₹157 Cr |
| ROE | −7.7% (FY26) |
| ROCE | −5.8% (FY26) |
| Debt to equity | 0.52 |
| 52-week high | ₹234.00 (4 Sep 2026) |
| 52-week low | ₹136.36 (27 Mar 2026) |
| 1-year return | −34.6% |

## Quarterly results (₹ crore, consolidated)

| Quarter | Revenue | Revenue YoY | Net profit | Net profit YoY | EPS (₹) |
| --- | --- | --- | --- | --- | --- |
| Q4 FY26 | ₹58 Cr | +30.0% | −₹5 Cr | −1,057.7% | −₹4.82 |
| Q3 FY26 | ₹38 Cr | −13.9% | −₹7 Cr | −6,572.7% | −₹6.88 |
| Q2 FY26 | ₹46 Cr | +11.1% | −₹7 Cr | — | −₹6.76 |
| Q1 FY26 | ₹45 Cr | +15.4% | −₹6 Cr | −1,030.0% | −₹5.40 |
| Q4 FY25 | ₹45 Cr | +11.8% | ₹1 Cr | −46.4% | ₹0.13 |
| Q3 FY25 | ₹44 Cr | +9.6% | ₹0 Cr | −90.9% | ₹0.10 |
| Q2 FY25 | ₹41 Cr | +9.9% | −₹1 Cr | −139.1% | −₹0.60 |
| Q1 FY25 | ₹39 Cr | +3.9% | ₹1 Cr | −67.0% | ₹0.65 |

## Annual results (₹ crore)

| Fiscal year | Revenue | Net profit |
| --- | --- | --- |
| FY25 | ₹169 Cr | ₹1 Cr |
| FY24 | ₹155 Cr | ₹6 Cr |
| FY23 | ₹172 Cr | ₹18 Cr |
| FY22 | ₹135 Cr | ₹14 Cr |
| FY21 | ₹80 Cr | ₹7 Cr |
| FY20 | ₹62 Cr | ₹1 Cr |

## Shareholding (30 Jun 2026)

- Promoters: 50.92%
- Non-institutions: 49.08%

## Peers

| Company | Price | Market cap | P/E | ROE |
| --- | --- | --- | --- | --- |
| [Medico Remedies](https://app.pivotnow.in/stock/MEDICO) | ₹20.71 | ₹172 Cr | 13.1 | — |
| [Vaidya Sane Ayu](https://app.pivotnow.in/stock/MADHAVBAUG) | ₹161.10 | ₹169 Cr | — | — |
| [Take Solutions](https://app.pivotnow.in/stock/TAKE) | ₹11.23 | ₹166 Cr | 38.7 | — |
| [Panchsheel Org](https://app.pivotnow.in/stock/PANCHSHEEL) | — | ₹159 Cr | — | — |
| [Auro Labs](https://app.pivotnow.in/stock/AUROLAB) | — | ₹156 Cr | — | — |
| [Kimia Bio](https://app.pivotnow.in/stock/KIMIABL) | — | ₹152 Cr | — | — |

## Questions and answers

### What is the share price of Natural Capsules today?

Natural Capsules (NSE: NATCAPSUQ) last closed at ₹150.40 on 22 Oct 2026. Its 52-week high is ₹234.00 and its 52-week low is ₹136.36.

### What is the market cap of Natural Capsules?

Natural Capsules' market capitalisation is ₹157 Cr (₹157 Cr) at the 22 Oct 2026 close, ranking 2408th among the NSE companies Pivot tracks.

### What is the ROE and ROCE of Natural Capsules?

Return on equity was −7.7% in FY26 and return on capital employed was −5.8% in FY26 (consolidated figures).

### Is Natural Capsules a debt-free company?

No. Natural Capsules' debt-to-equity ratio was 0.52 in FY26, with total debt of ₹55 Cr.

### What were Natural Capsules' latest quarterly results?

For Q4 FY26 (quarter ended 31 Mar 2026), Natural Capsules reported revenue of ₹58 Cr, +30.0% year on year, and net profit of −₹5 Cr, −1,057.7% year on year.

### How has Natural Capsules stock performed over the last year?

Natural Capsules' share price has fallen 34.6% over the past year, +5.3% over three months and −9.9% over one month, to the 22 Oct 2026 close.

### What is the shareholding pattern of Natural Capsules?

As of 30 Jun 2026: promoters 50.92%, non-institutions 49.08%.

### Who are Natural Capsules' competitors?

The listed Pharma & Healthcare companies closest to Natural Capsules by market cap are Medico Remedies, Vaidya Sane Ayu, Take Solutions, Panchsheel Org, Auro Labs and Kimia Bio.

### Is Natural Capsules a good stock to buy?

Pivot does not give buy or sell recommendations. This page sets out Natural Capsules' price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on NATCAPSUQ against its own history before risking money. This is analysis, not financial advice.

---

Sources: NSE end-of-day bars (Pivot's market data store); Company filings via Moneycontrol; Exchange shareholding-pattern filings. This is analysis, not financial advice. Pivot is not a broker or a SEBI-registered investment adviser.